Palomero, J. (., Panisello, C. (., Lozano-Rabella, M. (., Tirtakasuma, R. (., Díaz-Gómez, J. (., Grases, D. (., . . . Gros, A. (. (2022). Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer.
Citación estilo ChicagoPalomero, J. (Jara)|||/items/9a4a76fc-322d-434a-88d5-436ba26b1df2, et al. Biomarkers of Tumor-reactive CD4+ and CD8+ TILs Associate With Improved Prognosis in Endometrial Cancer. 2022.
Cita MLAPalomero, J. (Jara)|||/items/9a4a76fc-322d-434a-88d5-436ba26b1df2, et al. Biomarkers of Tumor-reactive CD4+ and CD8+ TILs Associate With Improved Prognosis in Endometrial Cancer. 2022.
Precaución: Estas citas no son 100% exactas.